Evotec SE (EVO) Long-Term Investments (2019 - 2026)
Evotec SE's (EVO) quarterly Long-Term Investments came in at $5088.1 in Q1 2026, down 5.95% year-on-year from $5409.8 in Q1 2025, and down 5.57% quarter-over-quarter from $5388.4 in Q4 2025.
Evotec SE (EVO) Long-Term Investments (2019 - 2026) Analysis & Trends
Evotec SE has disclosed Long-Term Investments across 8 years of filings, most recently posting $5088.1 for Q1 2026.
- Long-Term Investments for Q1 2026 came in at $5088.1, down 5.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $5088.1 (down 5.95% YoY), and the FY2025 annual result was $5388.4, down 99.99% from the prior year.
- Long-Term Investments came in at $5088.1 for Q1 2026 at Evotec SE, down from $5388.4 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $145.9 million in Q4 2023 to a low of $3915.2 in Q1 2024.
- The 5-year median for Long-Term Investments is $5818.4 (2025), against an average of $24.4 million.
- Peak annual rise in Long-Term Investments reached 38.17% in 2025, while the deepest fall reached 99.99% in 2025.
- Evotec SE's Long-Term Investments stood at $133.7 million in 2022, then advanced by 9.12% to $145.9 million in 2023, then sank by 74.83% to $36.7 million in 2024, then slumped by 99.99% to $5388.4 in 2025, then slipped by 5.57% to $5088.1 in 2026.
- The last three Long-Term Investments figures came in at $5088.1 (Q1 2026), $5388.4 (Q4 2025), and $5818.4 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.90 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 5,088.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,088.06 |
| Dec 31, 2025 | 5,388.36 |
| Sep 30, 2025 | 5,818.39 |
| Jun 30, 2025 | 5,090.42 |
| Mar 31, 2025 | 5,409.84 |
| Dec 31, 2024 | 36.73 Mn |
| Sep 30, 2024 | 4,523.57 |
| Mar 31, 2024 | 3,915.25 |
| Dec 31, 2023 | 145.89 Mn |
| Dec 31, 2022 | 133.70 Mn |
| Sep 30, 2022 | 173,307.23 |
| Jun 30, 2022 | 200,784.86 |
| Mar 31, 2022 | 241,909.79 |
| Dec 31, 2021 | 307.49 Mn |
| Dec 31, 2020 | 47.35 Mn |
| Dec 31, 2019 | 32.95 Mn |